The use of genetic alterations in the development of liver cancer drugs Journal Article
| Author: | Abou-Alfa, G. K. |
| Article Title: | The use of genetic alterations in the development of liver cancer drugs |
| Keywords: | protein expression; treatment outcome; overall survival; sorafenib; hepatitis c; liver cell carcinoma; ticilimumab; genetic manipulation; tumor cell; liver cancer; cytotoxic t lymphocyte antigen 4; alpha fetoprotein; intracellular signaling; programmed death 1 ligand 1; phase 2 clinical trial (topic); phase 3 clinical trial (topic); cabozantinib; nivolumab; tivantinib; lenvatinib; human; article; durvalumab |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 13 |
| Issue: | 12 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2015-12-01 |
| Start Page: | 826 |
| End Page: | 828 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 3 February 2016 -- Source: Scopus |
MSK Authors
-
571Abou-Alfa